{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:31:21Z","timestamp":1785583881878,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00198-025-07569-z","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:57:10Z","timestamp":1749664630000},"page":"1763-1766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prolonged hypercalcemia induced by teriparatide: a case report and literature review"],"prefix":"10.1007","volume":"36","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Permatasari","family":"Tjokrosaputro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bee Hwee","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Kian","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"7569_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916. https:\/\/doi.org\/10.1056\/NEJMra067395","journal-title":"N Engl J Med"},{"key":"7569_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"AB Hodsman","year":"2005","unstructured":"Hodsman AB, Bauer DC, Dempster DW et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703. https:\/\/doi.org\/10.1210\/er.2004-0006","journal-title":"Endocr Rev"},{"key":"7569_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00223-010-9424-6","volume":"87","author":"J Satterwhite","year":"2010","unstructured":"Satterwhite J, Heathman M, Miller PD et al (2010) Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcif Tissue Int 87:485\u2013492. https:\/\/doi.org\/10.1007\/s00223-010-9424-6","journal-title":"Calcif Tissue Int"},{"key":"7569_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","volume":"18","author":"ES Orwoll","year":"2003","unstructured":"Orwoll ES, Scheele WH, Paul S et al (2003) The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18:9\u201317. https:\/\/doi.org\/10.1359\/jbmr.2003.18.1.9","journal-title":"J Bone Miner Res"},{"key":"7569_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441. https:\/\/doi.org\/10.1056\/NEJM200105103441904","journal-title":"N Engl J Med"},{"key":"7569_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391:230\u2013240. https:\/\/doi.org\/10.1016\/S0140-6736(17)32137-2","journal-title":"Lancet"},{"key":"7569_CR7","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S et al (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028\u20132039. https:\/\/doi.org\/10.1056\/NEJMoa071408","journal-title":"N Engl J Med"},{"key":"7569_CR8","unstructured":"lilly E. What is known about the pharmacokinetics of FORTEO\u00ae (teriparatide injection)? https:\/\/medical.lilly.com\/us\/products\/assets\/vaultpdf\/en\/cadb07d1caf804ad9a5bb8da9e952032b54055043ff5b88edc8817f27462ffec\/what-is-known-about-the-pharmacokinetics-of-forteo-teriparatide-injection"},{"key":"7569_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/0253-7613.93869","volume":"44","author":"C Karatoprak","year":"2012","unstructured":"Karatoprak C, Kayatas K, Kilicaslan H et al (2012) Severe hypercalcemia due to teriparatide. Indian J Pharmacol 44:270\u2013271. https:\/\/doi.org\/10.4103\/0253-7613.93869","journal-title":"Indian J Pharmacol"},{"key":"7569_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/ckj\/sfs148","volume":"6","author":"N Ayasreh","year":"2013","unstructured":"Ayasreh N, Fernandez-Llama P, Lloret MJ et al (2013) Recombinant PTH associated with hypercalcaemia and renal failure. Clin Kidney J 6:93\u201395. https:\/\/doi.org\/10.1093\/ckj\/sfs148","journal-title":"Clin Kidney J"},{"key":"7569_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00774-014-0564-z","volume":"32","author":"M Hajime","year":"2014","unstructured":"Hajime M, Okada Y, Mori H, Tanaka Y (2014) A case of teriparatide-induced severe hypophosphatemia and hypercalcemia. J Bone Miner Metab 32:601\u2013604. https:\/\/doi.org\/10.1007\/s00774-014-0564-z","journal-title":"J Bone Miner Metab"},{"key":"7569_CR12","doi-asserted-by":"publisher","first-page":"802473","DOI":"10.1155\/2014\/802473","volume":"2014","author":"N Thiruchelvam","year":"2014","unstructured":"Thiruchelvam N, Randhawa J, Sadiek H, Kistangari G (2014) Teriparatide induced delayed persistent hypercalcemia. Case Rep Endocrinol 2014:802473. https:\/\/doi.org\/10.1155\/2014\/802473","journal-title":"Case Rep Endocrinol"},{"key":"7569_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.55729\/2000-9666.1010","volume":"12","author":"J Milosavljevic","year":"2022","unstructured":"Milosavljevic J, Thomas AM (2022) Teriparatide associated late hypercalcemia: a report of two cases and literature review. J Community Hosp Intern Med Perspect 12:54\u201358. https:\/\/doi.org\/10.55729\/2000-9666.1010","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"7569_CR14","doi-asserted-by":"publisher","first-page":"e54263","DOI":"10.7759\/cureus.54263","volume":"16","author":"Y Goto","year":"2024","unstructured":"Goto Y, Uchiyama Y, Fujikura T, Tashiro T, Yasuda H (2024) Teriparatide-associated hypercalcemia concomitant with acute kidney injury: a case-report. Cureus 16:e54263. https:\/\/doi.org\/10.7759\/cureus.54263","journal-title":"Cureus"},{"key":"7569_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00198-024-07082-9","volume":"35","author":"K McCarroll","year":"2024","unstructured":"McCarroll K, Carroll T, Neville M, Fitzpatrick D, Lannon R (2024) Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review. Osteoporos Int 35:1299\u20131302. https:\/\/doi.org\/10.1007\/s00198-024-07082-9","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07569-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:03:22Z","timestamp":1758747802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07569-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7569"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07569-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the patient included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}